🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Poland / NCT04214561
Enrolling by invitation Observational

Relationship Between Selected Parameters and Bruxism

NCT04214561 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2019-12-16
Last updated
2026-07-09

Condition(s) studied

Sleep BruxismSleep DisorderPsychosomatic DisorderPainAnxietyMental Status ChangeTemporomandibular Disorder

Investigational drug(s) / intervention(s)

Polysomnography

Polysomnography: Each of the patients will undergo polysomnography

Study summary

Bruxism is a common phenomenon. It is estimated that its prevalence in the adult population is 8-31%. Bruxism occurring during sleep is the activity of the masticatory muscles that appear during sleep, which can be rhythmic or phased and is not a movement disorder or sleep disorder in healthy people. It is currently believed that bruxism should not be considered a disorder. In healthy people, it is treated rather as behavior, which may be a risk factor for pathological clinical implications or a protective factor in the presence of other disease entities. The most common symptoms of bruxism include: pathological wear and tooth sensitivity, periodontal and oral mucosa damage, myalgia in the stomatognathic system, headache and prosthetic restoration damage. However, due to nocturnal occurrence, bruxism symptoms may go unnoticed for a long time, which means that patients are often unaware of this behavior. The etiology of bruxism is multifactorial and not fully understood. It is currently believed that it can be caused by genetic, psychological and exogenous factors. Due to the unclear etiology of bruxism, it is so important to conduct research that allows making a certain diagnosis and finding the causes of this phenomenon

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * diagnosed sleep bruxism * age between 18 and 70 Exclusion Criteria: * age under 18 * age over 70 * terminal general diseases * severe mental disorders * taking drugs that could falsify polysomnography * confirmed alcoholism * drug addiction

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Wroclaw Medical University Wroclaw Poland

More Wroclaw Medical University trials in Poland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04214561 on ClinicalTrials.gov ↗ ← All trials in Poland